These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11296593)

  • 21. Pharmacoeconomic analysis of hypertriglyceridemia treatment at medical institutions.
    Takahashi T; Saegusa Y; Takimoto Y; Shiragami M
    Yakugaku Zasshi; 2008 Dec; 128(12):1783-9. PubMed ID: 19043297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [High dosage stain protects heart and brain from recurrence].
    MMW Fortschr Med; 2008 Nov; 150(48):118-9. PubMed ID: 19125516
    [No Abstract]   [Full Text] [Related]  

  • 23. Low-dose atorvastatin therapy does not augment endothelial function in active hypercholesterolaemic males.
    Parnell MM; Chin-Dusting JP; Starr J; Kaye DM
    Br J Clin Pharmacol; 2003 Feb; 55(2):212-5. PubMed ID: 12580994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose atorvastatin in acute coronary and cerebrovascular syndromes.
    Lavie CJ; Milani RV
    JACC Cardiovasc Interv; 2010 Mar; 3(3):340-2. PubMed ID: 20298995
    [No Abstract]   [Full Text] [Related]  

  • 25. First head-to-head study comparing rosuvastatin and atorvastatin effects on the treatment of atherosclerosis.
    Cardiovasc J Afr; 2008; 19(1):60. PubMed ID: 18320096
    [No Abstract]   [Full Text] [Related]  

  • 26. Atorvastatin compared with simvastatin in patients with severe LDL hypercholesterolaemia treated by regular LDL apheresis.
    Geiss HC; Parhofer KG; Schwandt P
    J Intern Med; 1999 Jan; 245(1):47-55. PubMed ID: 10095816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too].
    MMW Fortschr Med; 2005 Aug; 147(33-34):51. PubMed ID: 16138641
    [No Abstract]   [Full Text] [Related]  

  • 28. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
    Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
    Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Ezetimib plus statin combination. A strong duo].
    MMW Fortschr Med; 2002 Nov; 144(48):53. PubMed ID: 12532547
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia.
    Jones PH; McKenney JM; Karalis DG; Downey J
    Am Heart J; 2005 Jan; 149(1):e1. PubMed ID: 15660024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?].
    Klose G
    MMW Fortschr Med; 2004 Jun; 146(26):14. PubMed ID: 15529683
    [No Abstract]   [Full Text] [Related]  

  • 32. Safety and efficacy of atorvastatin in heart transplant recipients.
    Patel DN; Pagani FD; Koelling TM; Dyke DB; Baliga RR; Cody RJ; Lake KD; Aaronson KD
    J Heart Lung Transplant; 2002 Feb; 21(2):204-10. PubMed ID: 11834348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No clinically relevant drug-drug interactions when dalcetrapib is co-administered with atorvastatin.
    Derks M; Abt M; Parr G; Meneses-Lorente G; Young AM; Phelan M
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1135-45. PubMed ID: 20738227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of atorvastatin when not administered daily.
    Ghattas AE; Pimenta J
    Arq Bras Cardiol; 2007 Nov; 89(5):294-300, 325-32. PubMed ID: 18066453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomised study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia.
    Jayaram S; Prasad HB; Sovani VB; Langade DG; Mane PR
    J Indian Med Assoc; 2007 Mar; 105(3):142-5, 150. PubMed ID: 17824470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PCSK9 inhibition: the next statin?
    Vogel RA
    J Am Coll Cardiol; 2012 Jun; 59(25):2354-5. PubMed ID: 22465426
    [No Abstract]   [Full Text] [Related]  

  • 37. Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial.
    Patti G; Ricottini E; Nusca A; Colonna G; Pasceri V; D'Ambrosio A; Montinaro A; Di Sciascio G
    Am J Cardiol; 2011 Jul; 108(1):1-7. PubMed ID: 21529740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-intensity statin treatment for coronary heart disease.
    Sacks FM
    JAMA; 2004 Mar; 291(9):1132-4. PubMed ID: 14996784
    [No Abstract]   [Full Text] [Related]  

  • 39. High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia.
    Wierzbicki AS; Lumb PJ; Semra YK; Crook MA
    QJM; 1998 Apr; 91(4):291-4. PubMed ID: 9666952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction.
    Teshima Y; Yufu K; Akioka H; Iwao T; Anan F; Nakagawa M; Yonemochi H; Takahashi N; Hara M; Saikawa T
    J Cardiol; 2009 Feb; 53(1):58-64. PubMed ID: 19167639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.